SoftBank is reportedly in advanced talks to acquire a majority stake in humanoid robot startup 1X at a valuation of approximately $6 billion, according to reports circulating around the deal. Should the transaction close, it would mark one of the most significant single bets yet by the Japanese conglomerate on humanoid robotics, a sector SoftBank founder Masayoshi Son has repeatedly identified as central to his broader thesis on the convergence of artificial intelligence and physical automation.
1X, known for its NEO humanoid robot platform, has positioned itself among the more closely watched entrants in a humanoid robotics field that has attracted extraordinary investor attention and correspondingly aggressive valuations over the past two years, as advances in AI-driven perception and control systems have made general-purpose humanoid platforms considerably more capable than the narrow, task-specific industrial robots that have dominated factory automation for decades.
A majority-stake acquisition, rather than a conventional minority-stake venture investment, would represent a materially deeper commitment than SoftBank's typical portfolio approach through its Vision Fund vehicles, suggesting the conglomerate may be pursuing tighter strategic control and integration with its broader robotics and AI infrastructure ambitions rather than treating 1X as a purely financial holding within a diversified technology portfolio.
SoftBank's history of large, occasionally contrarian bets on emerging technology sectors — spanning telecommunications, e-commerce, ride-hailing and, more recently, semiconductor design through its Arm holdings — has produced a mixed track record of spectacular successes alongside high-profile write-downs, most notably during the Vision Fund's turbulent period following the WeWork collapse. A majority stake in 1X would extend that pattern of concentrated, high-conviction bets into humanoid robotics, a sector where commercial viability at scale remains, by most industry accounts, still several years away from full realisation despite rapid recent technical progress.
The $6 billion valuation reportedly under discussion reflects the broader humanoid robotics sector's dramatic valuation inflation over a relatively compressed period, as investors race to establish positions in what many believe could become one of the defining physical technology categories of the coming decade, even as questions persist about near-term commercial viability, unit economics and the reliability of humanoid platforms operating outside tightly controlled demonstration environments.
For 1X, SoftBank's capital and strategic backing could provide meaningful advantages in a capital-intensive race where competitors — spanning well-funded American startups, Chinese state-supported robotics ventures and established automotive and technology conglomerates entering the category — are similarly racing to scale manufacturing capacity and secure commercial deployment partnerships ahead of what many industry participants view as an approaching period of market consolidation.
SoftBank's broader physical AI thesis extends across its existing investment portfolio, including its substantial holdings in Arm's semiconductor design business and various robotics-adjacent ventures, suggesting a strategic ambition to build an integrated technology stack spanning chip design, AI software and physical robotics hardware — a vertically integrated approach that, if successfully executed, could position the conglomerate advantageously across multiple layers of the emerging humanoid robotics value chain simultaneously.
Should the acquisition close at the reported valuation, it would also serve as a significant reference point for how the broader venture and private equity community prices humanoid robotics companies going forward, potentially accelerating valuation inflation across the sector as competing investors seek comparable exposure to companies perceived as occupying similarly advantaged competitive positions within the still-nascent humanoid robotics market.
As talks reportedly continue, the ultimate structure and terms of any SoftBank-1X transaction will offer important signals about how the world's most prominent technology conglomerate investor views the trajectory of humanoid robotics commercialisation — whether as an imminent, near-term commercial opportunity or as a longer-horizon strategic bet requiring the kind of patient, deep-pocketed capital that only a small handful of global investors can realistically provide at this scale.
1X's Norwegian origins add a further dimension to the potential transaction, reflecting the increasingly global geography of humanoid robotics innovation, which has expanded well beyond the traditionally dominant American and East Asian robotics hubs to include a growing cluster of well-funded European entrants competing for position within a still-forming global industry structure.
Regulatory scrutiny of the deal, should it proceed, may also factor into the transaction timeline, given growing government attention across multiple jurisdictions toward foreign investment in strategically sensitive robotics and AI companies, a dynamic that has increasingly complicated cross-border technology acquisitions even when, as in SoftBank's case, the acquiring entity is not directly state-controlled but nonetheless commands sufficient scale to attract heightened regulatory interest in transactions of this size.
For the broader humanoid robotics industry, a confirmed SoftBank-1X transaction at this scale would likely be interpreted as a bellwether signal of continued institutional conviction in the sector's long-term commercial potential, even amid periodic scepticism from other corners of the investment community about how quickly humanoid platforms can move from impressive demonstrations to reliable, cost-effective deployment across genuinely demanding industrial and commercial environments. Competitors to 1X will be watching the deal's eventual terms closely, both as a valuation benchmark for their own future fundraising conversations and as a signal of which strategic and financial investors are likely to remain most active in the category over the coming consolidation phase many industry participants anticipate. How SoftBank ultimately structures its involvement — as a controlling strategic parent or a more hands-off majority financial sponsor — will meaningfully shape 1X's operating autonomy and its ability to pursue partnerships with SoftBank's own competitors going forward. Whatever the outcome, the scale of capital reportedly under discussion underscores how rapidly humanoid robotics has moved from a speculative research curiosity to a category commanding some of the technology industry's largest and most closely watched capital commitments. Investors, founders and policymakers across the sector will be parsing the eventual deal terms for months, treating them as a reference point for pricing the next wave of humanoid robotics transactions likely to follow across both venture and strategic acquisition markets. For now, the reported talks alone are sufficient to reset expectations about how large individual humanoid robotics deals can realistically become, ahead of what many participants across the sector view as an inevitable wave of further consolidation among the field's leading players over the next several years.
